| [1] |
World Health Organization. Global tuberculosis report 2017. Geneva: World Health Organization, 2017.
|
| [2] |
World Health Organization. Roadmap for childhood TB: toward zero deaths. Geneva: World Health Organization, 2013.
|
| [3] |
McShane H, Jacobs WR, Fine PE , et al. BCG: myths, realities, and the need for alternative vaccine strategies. Tuberculosis (Edinb), 2012,92(3):283-288.
doi: 10.1016/j.tube.2011.12.003
URL
pmid: 22349516
|
| [4] |
Palmer CE, Long MW . Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis, 1966,94(4):553-568.
doi: 10.2307/3571854
URL
pmid: 5924215
|
| [5] |
Trunz BB, Fine P, Dye C . Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet, 2006,367(9517):1173-1180.
doi: 10.1016/S0140-6736(06)68507-3
URL
|
| [6] |
Roy A, Eisenhut M, Harris RJ , et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ, 2014,349:g4643.
doi: 10.1136/bmj.g4643
URL
|
| [7] |
Pereira SM, Barreto ML, Pilger D , et al. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial. Lancet Infect Dis, 2012,12(4):300-306.
doi: 10.1016/S1473-3099(11)70285-7
URL
|
| [8] |
World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. 2nd ed. Geneva: World Health Organization, 2014.
URL
pmid: 17131777
|
| [9] |
World Health Organization. Global tuberculosis programme and global programme on vaccines. Statement on BCG revaccination for the prevention of tuberculosis. Wkly Epidemiol Rec, 1995, 70(32): 229-231. Erratum in:Wkly Epidemiol Rec, 1995 , 70(34):246.
|
| [10] |
World Health Organization. BCG vaccine. WHO position paper. Wkly Epidemiol Rec, 2004,79(4):27-38.
URL
pmid: 14768305
|
| [11] |
赵爱华, 徐苗, 郑素华 , 等. 针对世界卫生组织对卡介苗两次文件立场观点差异的探讨. 中国防痨杂志, 2016,38(2):87-89.
doi: 10.3969/j.issn.1000-6621.2016.02.002
URL
|
| [12] |
Nguipdop-Djomo P, Heldal E, Rodrigues LC , et al. Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study. Lancet Infect Dis, 2016,16(2):219-226.
doi: 10.1016/S1473-3099(15)00400-4
URL
|
| [13] |
Tameris MD, Hatherill M, Landry BS , et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants pre-viously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet, 2013,381(9871):1021-1028.
doi: 10.1016/S0140-6736(13)60177-4
URL
|
| [14] |
Committee On Infectious Diseases, American Academy of Pediatrics. The red book—report of the Committee on Infectious Diseases. Elk Grove Village, Illinois: American Academy of Pediatrics, 2009.
|
| [15] |
中华医学会结核病学分会, 《中华结核和呼吸杂志》编辑委员会. γ-干扰素释放试验在中国应用的建议. 中华结核和呼吸杂志, 2014,37(10):744-747.
doi: 10.3760/cma.j.issn.1001-0939.2014.10.011
URL
|
| [16] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09.
|
| [17] |
Ramappa V, Aithal GP . Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management. J Clin Exp Hepatol, 2013,3(1):37-49.
doi: 10.1016/j.jceh.2012.12.001
URL
pmid: 3940184
|
| [18] |
Vilchèze C, Jacobs WR Jr . Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities. Microbiol Spectr, 2014, 2(4): MGM2-0014-2013.
|
| [19] |
Nimmo C, Doyle R, Burgess C , et al. Rapid identification of a Mycobacterium tuberculosis full genetic drug resistance profile through whole genome sequencing directly from sputum. Int J Infect Dis, 2017,62:44-46.
doi: 10.1016/j.ijid.2017.07.007
URL
|
| [20] |
World Health Organization. The end TB strateny. Geneva: World Health Organization, 2015.
|
京公网安备11010202007215号
ip访问总数: ip当日访问总数: 当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可
